Russell Brierley Joins Y-PRIME as Product Director, IRT & CSM

Y-Prime, Inc., a premier eClinical products and consulting company, today announced the appointment of Russell Brierley as Product Director, Interactive Response Technologies (IRT) and Clinical Supply Management (CSM). Brierley will lead the company’s supply chain platforms and activities.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This
"We continue to invest in bright, forward-thinking innovators who have the clinical research skills and experience needed to help our clients plan and manage clinical trials,” said Shawn Blackburn, Chief Executive Officer, Y-Prime, Inc.

Malvern, PA (PRWEB) June 17, 2014

Russell Brierley Joins Y-PRIME as Product Director, IRT & CSM

Y-Prime, Inc., a premier eClinical products and consulting company, today announced the appointment of Russell Brierley as Product Director, Interactive Response Technologies (IRT) and Clinical Supply Management (CSM). Brierley will lead the company’s supply chain platforms and activities.

Brierley is an industry expert with 30 years of experience in clinical supply chain management and drug development and he has served in leadership positions across the spectrum of distribution, packaging, manufacturing and process development/improvement. At Y-Prime Brierley is responsible for continuing the strong growth of the company’s IRT solution and driving market acceptance of the newly introduced eCSF, a Clinical Trial Supply & Forecasting platform – two intuitive and powerful tools that optimize decision-making and productivity as well as cost.

"We continue to invest in bright, forward-thinking innovators who have the clinical research skills and experience needed to help our clients plan and manage clinical trials,” said Shawn Blackburn, Chief Executive Officer, Y-Prime, Inc. “Russell brings deep insights into supply chain management, a critical piece of the clinical development process. His strategic leadership will help our customers manage resources and optimize the quality of their clinical supply chain.”

Prior to joining Y-Prime, Brierley served as Senior Director of North American Clinical Supply Chain, Senior Director of Clinical Development Manufacturing and Director of Biologics Process Development over a 21-year period at Teva, the world’s largest generic drug maker, and at Cephalon prior to its acquisition by Teva in 2011. While there, Brierley was responsible for managing the integrity of the clinical supply chain as well as forecasting and long-range planning in coordination with Clinical Research, Medical Affairs, Chemistry Manufacturing and Controls (CMC), Quality Assurance and Regulatory Affairs. He also designed and directed operations of a 23,000-square-foot cGMP facility for clinical manufacturing, packaging, labeling and distribution of clinical supplies servicing over 1,000 clinical studies. Prior to Cephalon, Brierley was a process development scientist at the Salk Institute Biotechnology Industrial Associates (SIBIA). He started his career in the biotechnology division at The Upjohn Company. Brierley has been an inventor on numerous patents during his tenure in the pharmaceutical industry. He has a bachelor of science degree in biology from the University of Massachusetts Lowell and a Master of Science in biotechnology from Worcester Polytechnic Institute.

“Y-Prime’s eClinical Solutions are best-in-class technologies that can help sponsors and clinical research organizations achieve a high degree of efficiency,” said Brierley. “I look forward to growing our customer base and to further integrating and advancing our IRT and CSM technologies to meet the needs of our clients in an increasingly competitive and complex clinical and regulatory environment.”

IRT & eCSF

Y-Prime’s Interactive Response Technology (IRT) is a cloud-based eClinical platform that solves challenges with patient randomization and clinical supplies management while providing real-time reporting via web and/or telephone user interfaces (IWR and IVR) that are natively integrated with all major Lab, EDC, CTMS and Depot platforms. It is a fluid, fully customizable system that can be rapidly configured to reduce waste and ensure accurate delivery of product while meeting study timelines.

Y-Prime recently introduced eCSF, a Clinical Trial Supply & Forecasting solution that enhances the ability to minimize drug overages, provides a high degree of visibility at the global, depot or individual site level, and allows sponsors to forecast and manage drug supply for clinical trials in real time.

About Y-Prime
Y-Prime, Inc. is the leader in software and technology used in clinical research, healthcare and IT. We help organizations use technology to increase productivity, reduce costs, minimize risk and grow strategically. Better information ... faster. Founded in 2006, Y-Prime is headquartered in Malvern, Pa., and can be found at http://www.y-prime.com. For more information, call 267-620-2000 or email contactus(at)y-prime(dot)com.

Follow us on Google+, Facebook, Twitter, YouTube and LinkedIn.

Contact:
Mike Beyer
Sam Brown Inc.
(312) 961-2502
mikebeyer(at)sambrown(dot)com


Contact